|
|
| GeneID |
55911
|
| Symbol |
APOB48R
|
| Synonyms |
-
|
| Description |
apolipoprotein B48 receptor |
| See related |
MIM:605220|HPRD:05561| |
| Locus tag |
- |
| Gene type |
protein-coding |
| Map location |
16p11 |
|
| |
|
|
| Gene set name |
Method of gene set |
Evidence |
Info |
| GSMA_IIE | genome scan meta-analysis (European-ancestry samples) | Psr: 0.01775 | |
|
| |
| General Gene Expression (microarray) ? |
|
 |
| |
| Gene Expression in Brain Regions (new) |
|
| |
| Top co-expressed genes in Brain Regions (new) |
|
| Gene | Pearson's Correlation | Spearman's Correlation | | |
| Top 10 positively co-expressed genes |
| ZBTB6 | 0.96 | 0.97 | | |
| RBM12 | 0.96 | 0.96 | | |
| ZNF845 | 0.96 | 0.95 | | |
| ZNF670 | 0.96 | 0.93 | | |
| SPAST | 0.96 | 0.96 | | |
| ZNF776 | 0.96 | 0.94 | | |
| RSBN1 | 0.96 | 0.95 | | |
| ZNF268 | 0.95 | 0.94 | | |
| MIER3 | 0.95 | 0.95 | | |
| MARCH7 | 0.95 | 0.96 | | |
Top 10 negatively co-expressed genes | | AIFM3 | -0.69 | -0.77 | | |
| FXYD1 | -0.69 | -0.87 | | |
| HLA-F | -0.69 | -0.76 | | |
| MT-CO2 | -0.68 | -0.87 | | |
| AF347015.31 | -0.68 | -0.84 | | |
| C5orf53 | -0.67 | -0.71 | | |
| AF347015.33 | -0.67 | -0.83 | | |
| AC018755.7 | -0.67 | -0.74 | | |
| AF347015.27 | -0.67 | -0.82 | | |
| IFI27 | -0.67 | -0.84 | | |
|
| Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0005319 | lipid transporter activity | IEA | | - |
| GO:0008034 | lipoprotein binding | TAS | | 10852956 |
| GO:0030226 | apolipoprotein receptor activity | IEA | | - |
| Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0008202 | steroid metabolic process | IEA | | - |
| GO:0008203 | cholesterol metabolic process | IEA | | - |
| GO:0006629 | lipid metabolic process | IEA | | - |
| GO:0006629 | lipid metabolic process | TAS | | 10852956 |
| GO:0006869 | lipid transport | IEA | | - |
| Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0005886 | plasma membrane | IEA | | - |
| GO:0042627 | chylomicron | IEA | | - |
| |